+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Xerostomia (Dry Mouth) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 344 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5922715
The global xerostomia (dry mouth) treatment market, which was valued at US$ 1.1 billion in 2024. By the end of 2031, the market is anticipated to reach a valuation of US$ 1.8 billion, indicating promising prospects for manufacturers of xerostomia treatment devices worldwide.

Strategies for Progress in the Xerostomia Treatment Device Industry

  • Increasing Usage of Medications Driving Demand: Manufacturers in the xerostomia treatment device sector are set to benefit from the growing incidence of Sjogren’s syndrome and the increased consumption of medications that can lead to dry mouth. Over 400 medicines have been identified to cause xerostomia, according to the National Institute of Dental and Craniofacial Research. Collaborations with pharmaceutical giants to produce drug therapy products offer significant growth opportunities.
  • Rising Awareness Among Healthcare Practitioners: Healthcare professionals are increasingly focused on identifying patients at risk of developing severe oral issues due to xerostomia, enabling them to provide valuable information on symptom management and relief. This heightened awareness among practitioners is generating substantial opportunities in the market.
  • Growing Drug Pipeline for Dry Mouth Treatment: The pharmaceutical industry's growing interest in developing various forms of products, such as gels, toothpaste, powders, liquids, and sprays, is expanding the xerostomia treatment product pipeline. A robust pipeline, combined with increased research and development activities, presents lucrative opportunities for manufacturers in the oral health product sector.

Factors Impacting Demand for Dry Mouth Treatment

"Low Public Awareness and Limited Treatment Options": Limited public awareness of xerostomia and the availability of only a few treatment options are key factors restraining demand for dry mouth treatment. Many people are unaware of the oral complications associated with diseases like HIV, cancer, and diabetes, as well as the severe consequences of xerostomia. Additionally, the availability of alternative treatment options, such as acupuncture and essential oils, may limit market growth.

Country-wise Insights

  • U.S. Xerostomia Treatment Market: The United States is expected to dominate the North America xerostomia treatment market due to superior healthcare infrastructure, readily available treatment options, favorable reimbursement policies, and increased awareness initiatives. The growing prevalence of xerostomia and related conditions in the U.S., including Sjogren’s syndrome, diabetes, Parkinson’s disease, and HIV, is propelling market growth.
  • Germany's Significance in European Market: Germany's aging population is experiencing a rise in oral problems like dry mouth. Healthcare providers, medical professionals, and dentists are actively engaged in educating consumers about the consequences of xerostomia and other oral issues. Growing research activities, an expanding product pipeline, and the presence of major players are creating ample opportunities for xerostomia treatment product manufacturers in Germany.
  • Emerging Market Potential in India: India is poised to witness an increased demand for xerostomia treatment due to government initiatives aimed at raising awareness and the rising prevalence of chronic diseases leading to dry mouth conditions. The adoption of industrial and health policies to boost domestic manufacturing of cancer drugs, resulting in lower therapy costs, is contributing to the growth of the market in India.

Competitive Landscape

Leading xerostomia treatment product suppliers are pursuing collaboration and joint venture strategies to enhance their market presence. Key players in the xerostomia (dry mouth) treatment industry are diligently seeking approvals from authorities such as the FDA or DCGA to introduce new product variants, further expanding their market footprint.

Key Companies Profiled

  • GlaxoSmithKline Plc
  • Daiichi Pharmaceutical Co., Ltd.
  • Bausch Health Companies Inc. (OraPharma)
  • ADVANZ PHARMA Corp. Limited
  • CCMed Ltd.
  • Elevate Oral Care, LLC
  • Orahealth Corporation
  • Forward Science
  • Parnell Pharmaceuticals, Inc.
  • Cyclacel Pharmaceuticals, Inc.
  • Midatech Pharma Plc
  • The 3M Company
  • Mission Pharmacal
  • Chattem, Inc. (Sanofi)
  • Colgate-Palmolive Company
  • EUSA Pharma, Inc.
  • Others

Key Segments Covered in Xerostomia Treatment Industry Survey

Xerostomia Treatment Market by Product:

  • Oral Sprays
  • Oral Solutions
  • Oral Liquids
  • Gels
  • Powders

Xerostomia Treatment Market by Age Group:

  • Paediatrics
  • Adults
  • Early Adults (18-34 Years)
  • Early Middle Age (35 – 44 Years)
  • Late Middle Age (45 – 64 Years)
  • Late Adulthood (Above 65+Years)

Xerostomia Treatment Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Mail Order Pharmacies
  • Hypermarkets and Supermarkets

Xerostomia Treatment Market by Region:

  • North America Xerostomia Treatment Market
  • Latin America Xerostomia Treatment Market
  • Europe Xerostomia Treatment Market
  • South Asia Xerostomia Treatment Market
  • East Asia Xerostomia Treatment Market
  • Oceania Xerostomia Treatment Market
  • Middle East & Africa Xerostomia Treatment Market


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Xerostomia (Dry Mouth) Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Xerostomia (Dry Mouth) Treatment Market Outlook, 2018 - 2031
3.1. Global Xerostomia (Dry Mouth) Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Oral Sprays
3.1.1.2. Oral Solutions
3.1.1.3. Oral Liquids
3.1.1.4. Gels
3.1.1.5. Powders
3.2. Global Xerostomia (Dry Mouth) Treatment Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Paediatrics
3.2.1.2. Adults
3.2.1.2.1. Early Adults (18-34 Years)
3.2.1.2.2. Early Middle Age (35 - 44 Years)
3.2.1.2.3. Late Middle Age (45 - 64 Years)
3.2.1.2.4. Late Adulthood (Above 65+Years)
3.3. Global Xerostomia (Dry Mouth) Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospital Pharmacies
3.3.1.2. Retail Pharmacies
3.3.1.3. Drug Stores
3.3.1.4. Mail Order Pharmacies
3.3.1.5. Hypermarkets and Supermarkets
3.4. Global Xerostomia (Dry Mouth) Treatment Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Xerostomia (Dry Mouth) Treatment Market Outlook, 2018 - 2031
4.1. North America Xerostomia (Dry Mouth) Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Oral Sprays
4.1.1.2. Oral Solutions
4.1.1.3. Oral Liquids
4.1.1.4. Gels
4.1.1.5. Powders
4.2. North America Xerostomia (Dry Mouth) Treatment Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Paediatrics
4.2.1.2. Adults
4.2.1.2.1. Early Adults (18-34 Years)
4.2.1.2.2. Early Middle Age (35 - 44 Years)
4.2.1.2.3. Late Middle Age (45 - 64 Years)
4.2.1.2.4. Late Adulthood (Above 65+Years)
4.3. North America Xerostomia (Dry Mouth) Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospital Pharmacies
4.3.1.2. Retail Pharmacies
4.3.1.3. Drug Stores
4.3.1.4. Mail Order Pharmacies
4.3.1.5. Hypermarkets and Supermarkets
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Xerostomia (Dry Mouth) Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
4.4.1.2. U.S. Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
4.4.1.3. U.S. Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.4.1.4. Canada Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
4.4.1.5. Canada Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
4.4.1.6. Canada Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Xerostomia (Dry Mouth) Treatment Market Outlook, 2018 - 2031
5.1. Europe Xerostomia (Dry Mouth) Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Oral Sprays
5.1.1.2. Oral Solutions
5.1.1.3. Oral Liquids
5.1.1.4. Gels
5.1.1.5. Powders
5.2. Europe Xerostomia (Dry Mouth) Treatment Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Paediatrics
5.2.1.2. Adults
5.2.1.2.1. Early Adults (18-34 Years)
5.2.1.2.2. Early Middle Age (35 - 44 Years)
5.2.1.2.3. Late Middle Age (45 - 64 Years)
5.2.1.2.4. Late Adulthood (Above 65+Years)
5.3. Europe Xerostomia (Dry Mouth) Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospital Pharmacies
5.3.1.2. Retail Pharmacies
5.3.1.3. Drug Stores
5.3.1.4. Mail Order Pharmacies
5.3.1.5. Hypermarkets and Supermarkets
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Xerostomia (Dry Mouth) Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.2. Germany Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
5.4.1.3. Germany Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.4. U.K. Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.5. U.K. Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
5.4.1.6. U.K. Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.7. France Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.8. France Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
5.4.1.9. France Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.10. Italy Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.11. Italy Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
5.4.1.12. Italy Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.13. Turkey Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.14. Turkey Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
5.4.1.15. Turkey Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.16. Russia Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.17. Russia Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
5.4.1.18. Russia Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.19. Rest of Europe Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.20. Rest of Europe Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
5.4.1.21. Rest of Europe Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Xerostomia (Dry Mouth) Treatment Market Outlook, 2018 - 2031
6.1. Asia Pacific Xerostomia (Dry Mouth) Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Oral Sprays
6.1.1.2. Oral Solutions
6.1.1.3. Oral Liquids
6.1.1.4. Gels
6.1.1.5. Powders
6.2. Asia Pacific Xerostomia (Dry Mouth) Treatment Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Paediatrics
6.2.1.2. Adults
6.2.1.2.1. Early Adults (18-34 Years)
6.2.1.2.2. Early Middle Age (35 - 44 Years)
6.2.1.2.3. Late Middle Age (45 - 64 Years)
6.2.1.2.4. Late Adulthood (Above 65+Years)
6.3. Asia Pacific Xerostomia (Dry Mouth) Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospital Pharmacies
6.3.1.2. Retail Pharmacies
6.3.1.3. Drug Stores
6.3.1.4. Mail Order Pharmacies
6.3.1.5. Hypermarkets and Supermarkets
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Xerostomia (Dry Mouth) Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.2. China Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
6.4.1.3. China Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.4. Japan Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.5. Japan Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
6.4.1.6. Japan Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.7. South Korea Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.8. South Korea Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
6.4.1.9. South Korea Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.10. India Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.11. India Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
6.4.1.12. India Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.13. Southeast Asia Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.14. Southeast Asia Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
6.4.1.15. Southeast Asia Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Xerostomia (Dry Mouth) Treatment Market Outlook, 2018 - 2031
7.1. Latin America Xerostomia (Dry Mouth) Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Oral Sprays
7.1.1.2. Oral Solutions
7.1.1.3. Oral Liquids
7.1.1.4. Gels
7.1.1.5. Powders
7.2. Latin America Xerostomia (Dry Mouth) Treatment Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Paediatrics
7.2.1.2. Adults
7.2.1.2.1. Early Adults (18-34 Years)
7.2.1.2.2. Early Middle Age (35 - 44 Years)
7.2.1.2.3. Late Middle Age (45 - 64 Years)
7.2.1.2.4. Late Adulthood (Above 65+Years)
7.3. Latin America Xerostomia (Dry Mouth) Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospital Pharmacies
7.3.1.2. Retail Pharmacies
7.3.1.3. Drug Stores
7.3.1.4. Mail Order Pharmacies
7.3.1.5. Hypermarkets and Supermarkets
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Xerostomia (Dry Mouth) Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.2. Brazil Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
7.4.1.3. Brazil Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1.4. Mexico Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.5. Mexico Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
7.4.1.6. Mexico Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1.7. Argentina Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.8. Argentina Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
7.4.1.9. Argentina Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1.10. Rest of Latin America Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.11. Rest of Latin America Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
7.4.1.12. Rest of Latin America Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Xerostomia (Dry Mouth) Treatment Market Outlook, 2018 - 2031
8.1. Middle East & Africa Xerostomia (Dry Mouth) Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Oral Sprays
8.1.1.2. Oral Solutions
8.1.1.3. Oral Liquids
8.1.1.4. Gels
8.1.1.5. Powders
8.2. Middle East & Africa Xerostomia (Dry Mouth) Treatment Market Outlook, by Age Group, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Paediatrics
8.2.1.2. Adults
8.2.1.2.1. Early Adults (18-34 Years)
8.2.1.2.2. Early Middle Age (35 - 44 Years)
8.2.1.2.3. Late Middle Age (45 - 64 Years)
8.2.1.2.4. Late Adulthood (Above 65+Years)
8.3. Middle East & Africa Xerostomia (Dry Mouth) Treatment Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospital Pharmacies
8.3.1.2. Retail Pharmacies
8.3.1.3. Drug Stores
8.3.1.4. Mail Order Pharmacies
8.3.1.5. Hypermarkets and Supermarkets
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Xerostomia (Dry Mouth) Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.2. GCC Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
8.4.1.3. GCC Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1.4. South Africa Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.5. South Africa Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
8.4.1.6. South Africa Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1.7. Egypt Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.8. Egypt Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
8.4.1.9. Egypt Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1.10. Nigeria Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.11. Nigeria Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
8.4.1.12. Nigeria Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Xerostomia (Dry Mouth) Treatment Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Xerostomia (Dry Mouth) Treatment Market by Age Group, Value (US$ Bn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Xerostomia (Dry Mouth) Treatment Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By End User vs By Application Heat map
9.2. Manufacturer vs by Age Group Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. GlaxoSmithKline Plc
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Daiichi Pharmaceutical Co., Ltd.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Bausch Health Companies Inc. (OraPharma)
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. ADVANZ PHARMA Corp. Limited
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. CCMed Ltd.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Elevate Oral Care, LLC
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Orahealth Corporation
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Parnell Pharmaceuticals, Inc.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Cyclacel Pharmaceuticals, Inc.
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Midatech Pharma Plc
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. The 3M Company
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Mission Pharmacal
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. Chattem, Inc. (Sanofi)
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Colgate-Palmolive Company
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. EUSA Pharma, Inc
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • GlaxoSmithKline Plc
  • Daiichi Pharmaceutical Co., Ltd.
  • Bausch Health Companies Inc. (OraPharma)
  • ADVANZ PHARMA Corp. Limited
  • CCMed Ltd.
  • Elevate Oral Care, LLC
  • Orahealth Corporation
  • Forward Science
  • Parnell Pharmaceuticals, Inc
  • Cyclacel Pharmaceuticals, Inc.
  • Midatech Pharma Plc.
  • Perrigo Company Plc.
  • Entod International
  • Laboratories Kin, SA
  • ICPA HEALTH PRODUCTS Ltd
  • Biocosmetic Laboratories
  • The 3M Company
  • Mission Pharmacal Company
  • Chattem, Inc. (Sanofi)
  • Cipla Ltd.
  • Fresenius Kabi
  • Colgate-Palmolive Company
  • EUSA Pharma

Methodology

Loading
LOADING...